Ambulatory Blood Pressure Reduction After Rosiglitazone Treatment In Normotensive Type 2 Diabetic Patients

• Status: Completed
• Trial end date: 2004-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study was to determine the effects of rosiglitazone in normotensive type 2 diabetic patients with regard to its blood-pressure-reducing effects.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Baskent University
• Treatments: Rosiglitazone

Criteria

Inclusion Criteria:

• Blood pressure of patients were in normotensive limits according to the JNC VII

• Diabetes mellitus treated with oral antidiabetics or diet

Exclusion Criteria:

• Any known hypertension, coronary artery disease, congestive hearth failure, renal disease or liver disease

• Anti-hypertensive treatment